Assistant Professor Voot Yin has identified the role of microRNA miR-101a in stimulating heart muscle cell growth and removing scar tissue. This breakthrough research holds promise for developing new drugs to regenerate damaged heart tissue and potentially treating other diseases involving muscle damage.
Research breakthrough reveals pancreatic tumours often lose miR-137 expression, triggering uncontrolled cell growth and cancer. Restoring normal miR-137 levels induces senescence and stops cells from spreading.
Researchers from Scripps Research Institute have identified microRNA miR-148a as a cause of autoimmune diseases like lupus. Elevated levels of this molecule allow self-reactive immune cells to escape and attack the body's own tissues.
A study published in eLife identified a novel mechanism that causes abnormal brain development in autism, a group of highly inheritable behavioral disorders. The research reveals how a specific microRNA regulates gene expression to impair brain development, leading to the characteristic symptoms of autism.
Researchers have discovered two microRNAs, miR-155 and miR-184, that are directly related to the severity of inflammation in trachoma. The study found that increased expression of miR-155 and decreased expression of miR-184 are associated with higher levels of conjunctival inflammation.
Researchers at Scripps Florida identified a memory suppressor microRNA called miR-980, which regulates neuronal excitability and inhibiting it improves memory. The study found links between miR-980 and autism spectrum disorder, suggesting that the microRNA may contribute to the development of the condition.
A study at The Wistar Institute revealed that Satb1 expression is required for proper immune response, but its prolonged presence drives immunosuppressive behavior. Silencing Satb1 in tumor-associated dendritic cells boosted T-cell activation and reduced inflammation.
Researchers at Tel Aviv University have developed a new blood test that can determine an individual's vulnerability to stress and PTSD. The test combines genetic testing with brain imaging to identify a specific alteration in the expression of microRNA miR-29c, which is linked to slow recovery from stress.
Researchers at Duke University have discovered that gut inflammation sparks colon cancer, with microRNA miR-34a playing a crucial role in controlling stem cell division. Elevated levels of miR-34a may serve as an early warning system for colon cancer, and its expression could be used to treat late-stage cancer.
MicroRNAs, specifically miR-125a, control endothelial cell proliferation and are increased in lung tissue of hypoxia-exposed animals. Inhibition of miR-125a increases expression of tumor suppressor genes, reducing cell proliferation.
Researchers at Thomas Jefferson University discovered that both strands of a tiny microRNA are active in suppressing genes in triple negative breast cancer cells. This breakthrough enables the design of specific blockers of one microRNA strand without imitating the opposite strand, opening a pathway to new treatments.
Researchers found p53 blocks PDL1 protein, which halts immune attack on lung cancer cells. High levels of p53 and miR-34a increase survival rates in patients with lung cancer.
Researchers have identified four microRNAs that play critical roles in controlling cholesterol and triglyceride levels, including miR-128-1 and miR-148a. These microRNAs regulate genes involved in lipid metabolism and may hold promise for treating cardiovascular disease.
Research published in the Journal of Leukocyte Biology suggests that ER stress is linked to poor glycemic control, dyslipidemia, and insulin resistance in patients with type 2 diabetes. Targeting ER stress may be an effective treatment strategy for diabetes.
Researchers at Nanjing University have discovered new epigenetic markers for colorectal cancer, which may offer a new approach for treatment. The study found that heterochromatin protein HP1γ was critical for CRC cell proliferation and could be specially regulated by miR-30a.
Researchers found that microRNA 506 acts as a tumor suppressor in gastric cancer, inhibiting angiogenesis and metastasis. Patients with high miR-506 expression have significantly longer survival times compared to those with low expression levels.
A first-of-its-kind study identified a potential gene target, FOX03, strongly associated with nonalcoholic fatty liver disease-related liver damage due to miR-182 regulation. The study found suppressed FOX03 protein levels in damaged livers, suggesting its role in the initiation of liver disease.
A new serum miRNA panel has been identified as a potential biomarker for diagnosing non-small-cell lung cancer (NSCLC) in ethnically diverse patients. The panel, consisting of five serum microRNAs, was found to have high sensitivity and specificity for detecting NSCLC in both Chinese and American cohorts.
Researchers found that miR-7 directly targets and suppresses the activity of growth factor receptor IGF1R, as well as the pro-oncogenic NF-κB pathway. Increasing miR-7 levels reduced tumor growth in mice and correlated with improved patient survival.
Researchers discovered a small RNA molecule called miR-148a plays a role in lung cancer resistance to TRAIL, and inhibiting NF-κB makes it more effective. This study suggests a way to overcome resistance and develop new treatments for lung cancer.
A study has identified a novel microRNA, miR-181a-5p, as a potential diagnostic breast cancer biomarker in the blood. The use of Droplet Digital PCR technology enabled the accurate quantification of this miRNA, which showed significant downregulation in the serum of patients with breast cancer.
Researchers have developed a novel control system to regulate therapeutic transgene expression by targeting the passenger strand of a specific microRNA. This approach achieves safe and specific regulation while sparing endogenous gene expression, offering potential for new gene therapy applications.
A new study reveals how synchronized gene activation is achieved in developing neurons through a TTP/miR-9 regulatory pair, which limits messenger destabilization and ensures coordinated accumulation of neuronal proteins.
A study published in the Journal of Clinical Investigation found that microRNA-132 plays a critical role in regulating the transition from inflammation to proliferation during wound healing. The researchers identified miR-132 as a therapeutic target for promoting healing and developing new treatments for chronic skin wounds.
Indiana University researchers found that restoring missing microRNA-29 in pancreatic cancer stromal cells reduced the viability and growth of cancerous cells. The study suggests that miR-29 could be a potent therapeutic agent against pancreatic cancer by targeting reactive tumor stroma.
Researchers have pinpointed the genetic cause of a rare form of blindness, which can present itself as a key-hole shaped defect in the eye. The miR-204 gene mutation has been linked to inherited retinal dystrophy associated with ocular coloboma.
Researchers have developed a novel delivery strategy using an aptamer to introduce functional microRNAs into cells, targeting breast cancer and blood vessel cells. The therapy shows anti-cancer and angiogenic activities, inhibiting tumor growth and protecting against atherosclerosis.
Researchers at NYU have found that microRNA can serve as a decoder ring to understand complex biological processes, highlighting the potential for miRNA to shed light on diseases such as coronary artery disease and cleft palates. By analyzing miR-200, the team identified a trio of glycans critical to cell movement and tumor metastasis.
Researchers at MD Anderson Cancer Center have identified a biomarker that may boost the response to chemotherapy in patients with ovarian cancer. The study found that miR-506 was associated with improved responses to chemotherapy drugs cisplatin and olaparib, leading to better overall survival.
In a study published in ETH Zurich, researchers discovered that the microRNA-200 family triggers the death of beta cells, leading to type 2 diabetes. By blocking miR-200 production, scientists can guarantee the survival of these vital cells. This finding has significant implications for the development of new treatments for diabetes.
Researchers discovered a critical role of the body clock in controlling the immune response to infection. A microRNA called miR-155 helps stop the macrophage clock, allowing it to become inflamed, while restoring clock function may provide new therapies for inflammatory disorders.
The American College of Physicians recommends screening for five common cancers: breast, colorectal, ovarian, prostate, and cervical. High-intensity screening may do more harm than good due to over-diagnosis and overtreatment. ACP advises focusing on tests that improve health and avoid harms.
A literature review highlights the alarming rise of opioid use in the US, with orthopaedic surgeons as the third highest prescribers. The study emphasizes the need for comprehensive risk assessment and patient-physician relationship trust to avoid overprescribing opioids.
Researchers at MD Anderson Cancer Center have uncovered a novel mechanism by which the tumor suppressor gene p53 regulates PD-L1, allowing non-small cell lung cancer to grow. MicroRNA delivery with existing treatments may represent a new therapeutic approach for lung cancer.
Researchers have unraveled the relationships between microRNA miR-22, bile acids, and Cyclin A2 in liver and colon cancer. The study found that miR-22 reduces Cyclin A2 expression levels, potentially leading to new cancer therapies.
Scientists have identified a small RNA molecule called miR-182 that can suppress cancer-causing genes in mice with glioblastoma, a deadly type of brain tumor. The new method uses nanotechnology to deliver the microRNA across the blood-brain barrier, targeting multiple oncogenes at once and increasing cancer cell death.
A new study has identified a group of molecules in prostate-cancer cells that can help distinguish which patients should be treated with radiation therapy if rising PSA levels indicate tumor recurrence. MicroRNA patterns, including miR-4516 and miR-601, may predict patient response to radiation therapy.
Researchers at Boston University School of Medicine identified a specific genetic signal, miR-10b-5p, that strongly correlates with disease severity and extent of neuronal death in Huntington's disease. This discovery may provide a faster and more effective way to determine the effectiveness of treatments.
New connections in gene regulation have been discovered in normal lung cells that may contribute to lung tumor formation. The researchers found that the transcription factor Nkx2-1 regulates lung cell proliferation, tumor growth, and progression by binding to microRNAs.
Two tiny bits of non-coding genetic material, miR-382 and miR-516b, have been found critical to stalling melanoma's spread in early-stage tumors. These microRNAs may help identify patients most likely to spread and benefit from more aggressive therapy.
Researchers at UC Riverside have identified microRNA-8 as a crucial regulator of mosquito reproduction, which plays an essential role in the female mosquito's 'fat body'. Depletion of miR-8 results in severe defects in egg development and deposition, highlighting its potential as a novel control strategy for mosquito populations.
Researchers used the mortality-to-incidence ratio to identify global disparities in colorectal cancer screening and treatment. Countries with lower-than-expected ratios have strong national health systems with formal screening programs.
Researchers at Virginia Commonwealth University have discovered a novel microRNA-gene interaction that could lead to new therapies for malignant glioma, the most common and deadly form of brain tumor. Increasing miR-184 expression slows glioma cell growth by regulating SND1, a cancer-promoting gene.
High levels of miR-21 in tumor stroma and epithelia are associated with poorer clinical outcomes in triple-negative breast cancer. The study found that changes in the tumor microenvironment play a crucial role in determining disease progression.
Scientists have developed a novel delivery platform that allows for the inhibition of microRNA activity, leading to controlled cancer growth. The breakthrough uses a peptide with low-pH induced transmembrane structure to target tumor cells, providing a promising new model for cancer therapeutics.
A UC San Francisco research team found that a specific microRNA, miR-30a-5p, plays a central role in the development of alcohol addiction by lowering levels of protective protein BDNF. Increasing miR-30a-5p levels in the brain region mPFC reduced BDNF and led to excessive drinking behavior.
A new study found that high levels of miRNA-378a-5p cause cell division anomalies in breast cancer cells, leading to abnormal chromosome numbers and promoting cancer growth. Elevated levels of this microRNA also correlate with aggressive forms of breast cancer.
University of Minnesota researchers have identified microRNAs miR-182 and miR-503 that contribute to the development of colon polyps into cancerous tumors. By targeting these microRNAs, physicians may be able to provide earlier and more specialized treatment for patients with a higher risk of colon cancer.
The European Organisation for Research and Treatment of Cancer (EORTC) will showcase its latest cancer research findings at the ESMO 2014 Congress. The conference will feature various sessions, including a joint symposium on clinical trials and posters focused on immunotherapy and gastrointestinal tumors.
Researchers at Yale University have discovered a microRNA mimic, miR-29, that can reverse the effects of pulmonary fibrosis in mouse models. The treatment uses intravenous delivery and has shown sustained effects on lung tissue. Further studies are needed to evaluate its therapeutic potential for human idiopathic pulmonary fibrosis.
A combination therapy of two miRNAs, let-7 and miR-34, has been shown to suppress tumor growth in an animal model of non-small-cell lung cancer. The study offers a promising therapeutic avenue for this aggressive malignancy.
Researchers have identified a gene network that fuels aggressive Acute Myeloid Leukemia and its precursor disease Myelodysplastic Syndrome. Inhibiting a key protein in this network may prevent leukemia cell growth and expansion.
A new study suggests that consuming resistant starch alongside red meat can lower the risk of colorectal cancer. The study found that butyrated resistant starch reduced levels of certain genetic molecules associated with cell proliferation and increased risk of cancer.
Researchers found that microRNA-124 significantly increases β-III tubulin and microtubule-associated protein-2 expression in BMSCs, promoting neuronal differentiation. Transplantation of miR-124-transfected BMSCs into spinal cord injury models improves motor function.
Scientists discovered a regulatory network contributing to abnormal cell proliferation in diseases like cancers and psoriasis. MicroRNA miR-21 is degraded through PAPD5, which breaks the pathway's disruption in many cancers.
Researchers found that microRNA miR-21 regulates the differentiation of neural crest stem cells (NCSCs) from human hair follicles into Schwann cells. By binding to the 3'-UTR of SOX2 mRNA, miR-21 down-regulates SOX protein expression, increasing SC differentiation capacity.
A study published in The Journal of Clinical Investigation reveals that the miR-130/301 microRNA family regulates diverse target genes, orchestrating a global proliferative response in diseased blood vessels. This discovery provides new therapeutic targets for treating pulmonary hypertension.
The pig whipworm genome sequence provides a genetic resource for investigating human autoimmune diseases, including inflammatory bowel disease and multiple sclerosis. Researchers found microRNAs regulating sexual development and secretory proteins with anti-inflammatory properties.
Researchers at McGill University discovered a tiny molecule, miR-1202, that regulates glutamate receptors and is lower in the brains of depressed individuals. The study found that this microRNA increases with antidepressant treatment, suggesting it could be a potential target for developing new treatments.
A study published in Endocrine-Related Cancer has identified specific molecules in seminal fluid that can detect prostate cancer and predict its severity. The presence of these microRNAs, particularly miR-200b, shows promise as a prognostic tool for indicating treatment urgency and type.